TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20713790

Group type: EXPERIMENTAL
Intervention: 1000 mg of methylprednisolone
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 306
Study: 18622294

Group type: EXPERIMENTAL
Intervention: Prophylaxis followed by preemptive therapy (ganciclovir for 30 days, then preemptive therapy with virologic monitoring)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Preemptive therapy alone (initiated at 100,000 DNA copies/mL whole blood)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both arms (prophylaxis and preemptive therapy)
Number of subjects: 21
Study: 16001108

Group type: EXPERIMENTAL
Intervention: Alprazolam (0.5 mg b.i.d.)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 12450909

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (5 mg elemental Zn/d)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 10614677

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens 0.625 mg/day continuously
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta‐estradiol 50 mg/day continuously
Number of subjects: 165

Group type: COMPARATOR
Intervention: Nontreated control group
Number of subjects: 165
Study: 7864416

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl infusion (2 micrograms/mL at 4‐10 mL/h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: IV morphine via patient-controlled analgesia (IV‐PCA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl infusion and IV morphine via PCA
Number of subjects: 20
Study: 2042178

Group type: EXPERIMENTAL
Intervention: Intraderma wheals (sterile water)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Dry needling
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (perinatal complications)
Number of subjects: 268
Study: 7191614

Group type: EXPERIMENTAL
Intervention: E2 and E3 orally in doses of 4-8 mg per day for 3 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Gestagen (1000 mg i.m. injection)
Number of subjects: 30
Study: 31039180

Group type: EXPERIMENTAL
Intervention: Walkasins ON
Number of subjects: 31

Group type: COMPARATOR
Intervention: Walkasins OFF
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Walkasins OFF-then-ON
Number of subjects: 31

Group type: COMPARATOR
Intervention: Walkasins ON-then-OFF
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Overall Functional Gait Assessment
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Normal fall-risk status
Number of subjects: 31
Study: 28544029

Group type: EXPERIMENTAL
Intervention: True RIII feedback in chronic back pain subjects (n=18)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham RIII feedback in chronic back pain subjects (n=15)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: True RIII feedback in healthy control subjects (n=15)
Number of subjects: 33
Study: 25732567

Group type: EXPERIMENTAL
Intervention: Blood NMR assessed at Time-1 and Time-2 (2-3 weeks apart)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: NMR categorized into slow (NMR ≤ 0.24) or normal/fast (NMR ≥ 0.25)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: NMR quartiles classification
Number of subjects: 72
Study: 24113039

Group type: EXPERIMENTAL
Intervention: Argatroban (200 µg/kg bolus, followed by 350 µg·kg(‐1)·h(‐1) i.v. infusion)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Heparin (100 U/kg via artery sheaths)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Argatroban
Number of subjects: 300

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 300
Study: 21377804

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) 24 IU
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 19906103

Group type: EXPERIMENTAL
Intervention: Anti-EGFR monoclonal antibody
Number of subjects: 4186

Group type: COMPARATOR
Intervention: No anti-EGFR monoclonal antibody (Control)
Number of subjects: 4186
Study: 17293063

Group type: EXPERIMENTAL
Intervention: 200 microg L-selenomethionine daily for 6 months
Number of subjects: 0
Study: 15510787

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment in addition to routine diabetes treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Domperidone treatment in addition to routine diabetes treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment in addition to routine diabetes treatment
Number of subjects: 80
Study: 11578021

Group type: EXPERIMENTAL
Intervention: 300mg ASU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 600mg ASU
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10023308

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU) + Leucovorin (LV)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Raltitrexed (Tomudex)
Number of subjects: 439
Study: 7931490

Group type: EXPERIMENTAL
Intervention: Granisetron 5 micrograms/kg
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Granisetron 10 micrograms/kg
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Granisetron 20 micrograms/kg
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Granisetron 40 micrograms/kg
Number of subjects: 184
Study: 2979273

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg taken at 18.15 hours after a standard meal at 18.00 hours
Number of subjects: 9

Group type: COMPARATOR
Intervention: Ranitidine 300 mg taken at 18.15 hours after a late meal at 22.00 hours
Number of subjects: 9
Study: 29152675

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation at 50,000 IU/week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28107090

Group type: EXPERIMENTAL
Intervention: Panitumumab plus mFOLFOX6
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab plus mFOLFOX6
Number of subjects: 0
Study: 26038879

Group type: EXPERIMENTAL
Intervention: Palm cooling between sets
Number of subjects: 0

Group type: COMPARATOR
Intervention: No palm cooling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Palm cooling between sets and post-exercise
Number of subjects: 0
Study: 23089512

Group type: EXPERIMENTAL
Intervention: TALK social worker intervention (video and booklet plus patient and family social worker visits)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: TALK education intervention (video and booklet)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care (routine care with nephrologists)
Number of subjects: 130
Study: 20647564

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 6921

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting
Number of subjects: 6921

Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 6921

Group type: EXPERIMENTAL
Intervention: Angiographic characteristics
Number of subjects: 6921

Group type: EXPERIMENTAL
Intervention: Clinical parameters
Number of subjects: 6921
Study: 17370343

Group type: EXPERIMENTAL
Intervention: Dichotic listening of consonant-vowel syllables /da/-/ba/ (true DL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dichotic listening of consonant-vowel syllables /da/-/ka/ (sham DL)
Number of subjects: 10
Study: 16784030

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 0
Study: 12719279

Group type: EXPERIMENTAL
Intervention: Ezetimibe (10 mg) plus atorvastatin (10, 20, 40, or 80 mg)
Number of subjects: 628

Group type: COMPARATOR
Intervention: Atorvastatin (10, 20, 40, or 80 mg)
Number of subjects: 628

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 628
Study: 11256891

Group type: EXPERIMENTAL
Intervention: Supervised 9-month step-aerobic program (two sessions per week, each session complemented with additional jumps)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (62 girls, 33 premenarcheal, 29 postmenarcheal)
Number of subjects: 64
Study: 8994512

Group type: EXPERIMENTAL
Intervention: LY293111 (112 mg three times daily for seven days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1453314

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined therapy of chlorpheniramine and cimetidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3933202

Group type: EXPERIMENTAL
Intervention: Pyoimmunogen vaccine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anti-P. aeruginosa plasma
Number of subjects: 60
Study: 31174360

Group type: EXPERIMENTAL
Intervention: 75% basal insulin dose
Number of subjects: 9

Group type: COMPARATOR
Intervention: 100% basal insulin dose
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both trial arms (75% and 100% basal insulin)
Number of subjects: 9
Study: 29106924

Group type: EXPERIMENTAL
Intervention: Heated‐humidified gases
Number of subjects: 273

Group type: COMPARATOR
Intervention: Unconditioned gases
Number of subjects: 273
Study: 26797016

Group type: EXPERIMENTAL
Intervention: Umeclidinium/vilanterol
Number of subjects: 389

Group type: COMPARATOR
Intervention: Umeclidinium
Number of subjects: 389

Group type: COMPARATOR
Intervention: Vilanterol
Number of subjects: 389
Study: 24844026

Group type: EXPERIMENTAL
Intervention: Zucchelli's technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tunnel technique with subepithelial connective tissue graft (SECTG)
Number of subjects: 20
Study: 22743744

Group type: EXPERIMENTAL
Intervention: 1% buffered lidocaine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sterile normal saline
Number of subjects: 55
Study: 19709787

Group type: EXPERIMENTAL
Intervention: 8.8 g/d of plant stanols as esters
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 49
Study: 17408407

Group type: EXPERIMENTAL
Intervention: Pneumatic tourniquet inflation (Ti; n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No pneumatic tourniquet inflation (Tn; n = 12)
Number of subjects: 24
Study: 16061711

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg 8 hourly for 12 weeks (n = 9)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg 8 hourly for 12 weeks (n = 5)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (n = 8)
Number of subjects: 22
Study: 12429323

Group type: EXPERIMENTAL
Intervention: Polydimethylsiloxane (Macroplastique)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Dextranomer/hyaluronic acid copolymer (Deflux)
Number of subjects: 114
Study: 10335994

Group type: EXPERIMENTAL
Intervention: Packed RBC units stored for 42 days
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Platelet components transfused to 25 patients
Number of subjects: 44
Study: 8944004

Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention (4DFR)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention (FFQ)
Number of subjects: 303
Study: 1826370

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Diclofenac (200 mg/day for 4 days)
Number of subjects: 8
Study: 6123337

Group type: EXPERIMENTAL
Intervention: Lorazepam 0.05 mg kg‐1
Number of subjects: 199

Group type: COMPARATOR
Intervention: Trimeprazine 3 mg kg‐1
Number of subjects: 199
Study: 31351449

Group type: EXPERIMENTAL
Intervention: Combined intervention including 'My Knee Exercise' website and 24-week behaviour change SMS exercise adherence program
Number of subjects: 206

Group type: COMPARATOR
Intervention: Education control website 'My Knee Education' containing OA and exercise information only
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 206

Group type: COMPARATOR
Intervention: Education control
Number of subjects: 206
Study: 29025134

Group type: EXPERIMENTAL
Intervention: Cannabis without cannabidiol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cannabis with cannabidiol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cannabis (both types)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 26332777

Group type: EXPERIMENTAL
Intervention: Vibration group (VG) - trained using a ramp-up baseline with superimposed 30 Hz sinusoidal vibration
Number of subjects: 40

Group type: COMPARATOR
Intervention: No-vibration group (NVG) - trained using the same baseline but without vibration
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dumbbell group (DG) - trained using dumbbells
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG) - not trained
Number of subjects: 40
Study: 25018142

Group type: EXPERIMENTAL
Intervention: Endoscopic control at 3 months (Group 1)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Endoscopic control at 6 months (Group 2)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Medical therapy with B blockers
Number of subjects: 102
Study: 22459327

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy plus healthy living skills
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy plus affect regulation training
Number of subjects: 81
Study: 19007927

Group type: EXPERIMENTAL
Intervention: Wire-guided cannulation (WGC) without contrast injection
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional cannulation with contrast injection
Number of subjects: 300
Study: 17985004

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus acetylsalicylic acid (ASA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) alone
Number of subjects: 0
Study: 15364317

Group type: EXPERIMENTAL
Intervention: Immune modulation therapy (IMT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 11278160

Group type: EXPERIMENTAL
Intervention: 100mcg transdermal estradiol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 50mcg transdermal estradiol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Transdermal placebo
Number of subjects: 36
Study: 9549810

Group type: COMPARATOR
Intervention: Control arm (no Tamoxifen treatment)
Number of subjects: 4875
Study: 8015795

Group type: EXPERIMENTAL
Intervention: Experimental dressing (chlortetracycline, aspirin, local anesthetics)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no dressing)
Number of subjects: 50
Study: 2563270

Group type: EXPERIMENTAL
Intervention: Rimiterol (2 puffs, 400 micrograms)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1257731

Group type: EXPERIMENTAL
Intervention: Long-time treatment with corticosteroids and azathioprine
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Short-time treatment (as short as possible)
Number of subjects: 121

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 121
Study: 31164148

Group type: EXPERIMENTAL
Intervention: 540,000 IU cholecalciferol followed by monthly supplementation
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Vitamin D oral supplementation
Number of subjects: 410
Study: 28739541

Group type: EXPERIMENTAL
Intervention: Virtual Advisor program (computer-based embodied conversational agent named 'Carmen')
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peer Advisors (trained human advisors)
Number of subjects: 0
Study: 24939117

Group type: EXPERIMENTAL
Intervention: Adjustable LED task lights
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 22610590

Group type: EXPERIMENTAL
Intervention: tDCS + VI intervention
Number of subjects: 18
Study: 21747329

Group type: EXPERIMENTAL
Intervention: Smoke alarm button test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemical smoke test
Number of subjects: 0
Study: 18298197

Group type: EXPERIMENTAL
Intervention: LED curing unit
Number of subjects: 65

Group type: COMPARATOR
Intervention: Halogen light
Number of subjects: 65
Study: 16827769

Group type: EXPERIMENTAL
Intervention: 15 ml of 0.5% bupivacaine
Number of subjects: 85

Group type: COMPARATOR
Intervention: 15 ml of 0.9% saline (control)
Number of subjects: 85
Study: 15457989

Group type: EXPERIMENTAL
Intervention: Timolol-gel alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Latanoprost alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Timolol-gel and latanoprost in combination
Number of subjects: 45
Study: 11506112

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9250102

Group type: EXPERIMENTAL
Intervention: Fish-oil concentrate (FOC; 41% eicosapentaenoic acid and 23% docosahexaenoic acid)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (olive oil, OO)
Number of subjects: 26
Study: 8282290

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg, increased to 10 mg if diastolic BP > 90 mmHg
Number of subjects: 89
Study: 2941290

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg b.i.d. for five days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31757656

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted distal gastrectomy (LADG)
Number of subjects: 921

Group type: COMPARATOR
Intervention: Open distal gastrectomy (ODG)
Number of subjects: 921
Study: 29982690

Group type: COMPARATOR
Intervention: GSK2881078
Number of subjects: 0
Study: 28277289

Group type: EXPERIMENTAL
Intervention: Uncertainty self‐management telephone intervention (SMI)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Liver disease education (LDE)
Number of subjects: 115
Study: 26181037

Group type: EXPERIMENTAL
Intervention: mHealth intervention plus usual care (n = 85)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Usual care alone (n = 86)
Number of subjects: 171
Study: 24022443

Group type: EXPERIMENTAL
Intervention: Watchful Waiting (WW)
Number of subjects: 254
Study: 21382509

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Proactive recruitment of smokers in social networks
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Social network members
Number of subjects: 516
Study: 18320916

Group type: EXPERIMENTAL
Intervention: Formoterol fumarate (12 microg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Albuterol nebulizer (2.5 mg)
Number of subjects: 34
Study: 17036557

Group type: EXPERIMENTAL
Intervention: 1 g/d of valacyclovir for 60 days
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 15529837

Group type: EXPERIMENTAL
Intervention: Oral antibiotics (7-day outpatient course)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (7-day outpatient course)
Number of subjects: 0
Study: 11414776

Group type: EXPERIMENTAL
Intervention: Cervical mobilisation technique
Number of subjects: 30
Study: 9268953

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 439

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 439
Study: 8097215

Group type: COMPARATOR
Intervention: OpSite (traditional dressing)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: OpSite IV3000 (new dressing)
Number of subjects: 101
Study: 3526609

Group type: EXPERIMENTAL
Intervention: Prostacyclin (PGI2) treatment (6 ng/kg/min, n = 13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 26
Study: 29805306

Group type: EXPERIMENTAL
Intervention: Nomogram incorporating hematological biomarkers and clinical characteristics for predicting overall survival (OS)
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Risk groups based on total points (TPs) of the nomogram
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Independent factors in the nomogram for OS
Number of subjects: 690
Study: 27619215

Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 139

Group type: COMPARATOR
Intervention: Normal weight healthy reference group
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Overall study population
Number of subjects: 139
Study: 24275010

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 37
Study: 23534179

Group type: EXPERIMENTAL
Intervention: Psycho-educative intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 20484472

Group type: COMPARATOR
Intervention: hCG 0 IU
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: hCG 15 IU
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: hCG 60 IU
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: hCG 125 IU
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Testosterone gel 7.5 g daily
Number of subjects: 37
Study: 18777232

Group type: EXPERIMENTAL
Intervention: Anxiety reduction imagery condition
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anxiety induction imagery condition
Number of subjects: 60

Group type: COMPARATOR
Intervention: Jumping to conclusions (JTC) reasoning bias
Number of subjects: 60

Group type: COMPARATOR
Intervention: JTC reasoning bias
Number of subjects: 60
Study: 11848432

Group type: EXPERIMENTAL
Intervention: Suture fixation to the scrotal wall
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Narrowing of the neck of the dartos pouch without fixation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Suture fixation with narrowing of the dartos fascial opening
Number of subjects: 150
Study: 9759991

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 20 mg b.i.d. for 8 weeks (could be doubled once)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 21
Study: 7936822

Group type: EXPERIMENTAL
Intervention: Bone mineral content (BMC) supplementation
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 85
Study: 3214383

Group type: EXPERIMENTAL
Intervention: Lamicel inserted for 6 hours
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laminaria tent inserted for 8 hours
Number of subjects: 100